Related Experiment Videos
Emerging therapeutic targets in psoriasis.
Andrew I Bayliffe1, Richard A Brigandi, H Jeffrey Wilkins
1GlaxoSmithKline, Park Road, Ware, Hertfordshire SG12 0DP, UK.
Current Opinion in Pharmacology
|May 14, 2004
Summary
Biopharmaceuticals targeting specific molecules are revolutionizing psoriasis treatment by revealing new pathogenic mechanisms beyond skin cells. This research identifies key molecules for future drug development, offering hope for novel therapies.
Area of Science:
- Immunodermatology
- Molecular Biology
- Pharmacology
Background:
- Psoriasis pathogenesis understanding has evolved from epidermal focus to include keratinocyte factors, inflammation, and angiogenesis.
- Biopharmaceuticals targeting specific molecules have significantly advanced psoriasis research.
Purpose of the Study:
- To review key molecules involved in psoriasis pathogenesis.
- To evaluate current and future therapeutic targets for psoriasis.
Main Methods:
- Literature review of recent studies on psoriasis pathogenesis.
- Analysis of molecular targets investigated in vitro and in vivo.
Main Results:
- Several key molecules implicated in psoriasis pathogenesis have been identified.
- Some molecules are under investigation as therapeutic targets, while others require further study.
- Upregulated molecules in psoriasis present opportunities for novel therapeutic strategies.
Conclusions:
- The understanding of psoriasis pathogenesis has broadened, implicating multiple molecular pathways.
- Targeting specific molecules offers promising avenues for developing next-generation psoriasis therapies.
- Continued research into molecular mechanisms is crucial for identifying effective drug targets.